Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Inclusion Criteria: * Femal patient aged \> 18 years * Histologically proven diagnosis of cancer of the ovary, the fallopian tube or peritoneal * patients whose disease progresses or relapses * patients having received at least a line of platinum-based chemotherapy * patients whose treatment of relapse is envisaged to comprise paclitaxel * patients who will receive EPO for treatment of their anaemia * ECOG performans status \< 2 * life expectancy \> 16 weeks * patient who has clearly given her consent by signing on informed consent form prior to participation Exclusion Criteria: * peripheral neuropathy grade \> 2 * history of ischemic cardiopathy, congestive heart failure (NYHA\>2), arrhythmia, hypertension or significant valvulopathy * abnormal biological values * A therapy or a serious disease which could involve a risk for the patient or interfere with the aims of the study * patient who is pregnant, breast feeding or using inadequate contraception * concomitant therapy by a potentially neurotoxic drug * concomitant inclusion in another therapeutic trial which could interfere with the aims of the study * patient who for familial, sociological, geographical or psychological condition could not be followed correctly